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Background Essential tremor (ET) is one of the most common neurological disor-
ders that impairs quality of life and leads to disability and social handicap. It was 
estimated that approximate 0.9% of people worldwide were affected by ET. The 
last decade has seen new investigations on the epidemiology of ET, enabling us to 
provide an up-to-date estimation of ET prevalence, with emphasis on age and sex.
Methods We searched PubMed, Medline, Embase and Global Health for studies 
that reported the prevalence of ET in the general population. Potential sources 
of heterogeneity were examined by age-adjusted meta-regression. The age- and 
sex-specific prevalence of ET was constructed with a multilevel mixed-effects me-
ta-regression.
Results A total of 29 articles were included in our systematic review and me-
ta-analysis. The prevalence of ET increased dramatically with advancing age, where 
the prevalence estimate in people aged under 20 years was 0.04% (95% confi-
dence interval [CI] = 0.00-0.29) and that in elderly aged 80 years and above was 
2.87% (95% CI = 1.07-7.49). ET was consistently more common in males than 
in females. In 2020, the overall prevalence of ET in the general population was 
0.32% (95% CI = 0.12-0.91), and the prevalence was higher in males (0.36%, 
95% CI = 0.14-1.03) than in females (0.28%, 95% CI = 0.11-0.79). In 2020, the 
number of people affected by ET was 24.91million (95% CI = 9.51-70.92), among 
whom 56% were males.
Conclusions This study provides an up-to-date estimation of ET prevalence in the 
general population throughout the whole life span, with emphasis on age and sex. 
The adoption of an internationally acknowledged diagnostic strategy is prompted 
in future epidemiological investigations.
Protocol registration PROSPERO (CRD42020203979)
Cite as: Song P, Zhang Y, ZHa M, Yang Q, Ye X, Yi Q, Rudan I; Global Health 
Epidemiology Reference Group (GHERG). The global prevalence of essential tremor, 
with emphasis on age and sex: A meta-analysis. J Glob Health 2021;11:04029.
Essential tremor (ET), primarily characterised by a rhythmic oscillation of agonist 
and antagonist muscle groups, is one of the most common neurological disorders 
[1-3]. ET generally involves head, vocal cords and lower limbs, with a variable fre-
quency of 4-12 Hz [4,5]. The traditional conception of ET being a relatively mono-
symptomatic clinical disorder has been challenged by collective evidence [6,7]. Ac-
cording to the 2018 consensus statement on tremor disorders by the International 
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ET affects people of all ages and has a bimodal distribution of age at onset, respectively peaking at the second 
and sixth decades [2,8]. Although ET is generally regarded as a benign neurological disorder, a wide range of 
symptoms and comorbidities, including but not limited to intention tremor, gait ataxia, cognitive abnormal-
ities, anxiety and depression, could accumulate as ET progresses, leading to impaired quality of life, disabili-
ty and social handicap [9,10]. From both the clinical and public health perspectives, reliable estimates of ET 
prevalence are desirable for guiding adequate treatment, prevention and management.
A systematic review of global prevalence data published up to 2009 was conducted by ED Louis and colleagues 
in 2010, suggesting that ET affected approximately 0.9% of the world population [3]. Marked heterogeneity 
between the reported ET prevalence worldwide was noted, largely due to variations in the investigated sample 
(such as age, sex, ethnicity), case definition and diagnostic approaches, etc. [3,6]. Since then, a growing body 
of epidemiological investigations on ET has become available during the last decade [11-14]. Until recently, 
the valuable report by ED Louis and colleagues still serves as by far the best source of quantitative information 
on the worldwide prevalence of ET, highlighting the need for an updated systematic review and meta-analy-
sis of this topic.
In this study, we conducted an updated systematic review of population-based studies that reported the prev-
alence of ET in the general population. The primary aim of our study was to determine the global prevalence 
of ET in the general population based on current evidence. Furthermore, we sought to identify potential asso-
ciated factors of ET, and to establish the age- and sex-specific prevalence and cases of ET in 2020.
METHODS
Search strategy and study selection
This systematic review was performed and reported in accordance with the Preferred Reporting Items for Sys-
tematic reviews and Meta-Analysis (PRISMA) [15]. The review protocol was registered online on PROSPERO 
a prior (CRD42020203979).
By systematically searching four bibliographic databases, namely PubMed, Medline, Embase and Global Health, 
two authors (MZ and QY) independently identified cross-sectional and longitudinal studies published between 
January 2000 and December 2019 that reported the prevalence of ET in the general population. Search terms 
related to ET (“essential tremor”) and prevalence (“prevalence” or “epidemiology”) were combined without 
language limitations (see Table S1 in the Online Supplementary Document for the complete search strate-
gies). In addition, the authors screened the reference lists of relevant systematic reviews to complement the 
database searches.
Two authors (MZ and QY) independently screened the titles and abstracts of all records, and then reviewed 
full-texts of all potentially relevant articles to determine eligibility. Studies met inclusion criteria if they were 
conducted in a sample that was representative of the general population and reported the prevalence of ET 
(sample size and cases). The study design and diagnostic approaches should have been clearly addressed. Stud-
ies were excluded if they were confined to a purposely-selected sample (cognitively impaired patients, people 
with Parkinson disease, etc.). Multiple publications of the same investigation were compared, and the one with 
the most comprehensive results was chosen. Discordant results were resolved by discussion between the two 
authors or by consulting a senior author (PS).
Data extraction and quality assessment
Three authors (YZ, MZ and QY) independently extracted and cross-checked data from the included arti-
cles using a standardised data extraction form. Characteristics of study (authors, publication year, study lo-
cation, country, World Health Organization [WHO] region, World Bank [WB] region, study period, sam-
pling method, study design) and participants (age range and average age, female proportion, sample size), 
diagnostic approaches and definitions of ET were collected. Prevalence data, including sample size, ET cases 
and reported prevalence, were abstracted by age group and sex when available. The WHO regions includ-
ed African Region (AFR), Region of the Americas (AMR), South-East Asia Region (SEAR), European Region 
(EUR), Eastern Mediterranean Region (EMR) and Western Pacific Region (WPR), and the WB regions in-
cluded high-income countries (HIC) and low- and middle-income countries (LMIC). For studies where the 
investigation years were not available, we assigned them as five years before publication, based on the aver-
age time lag between investigation and publication from articles with available information (Table S2 in the 
Online Supplementary Document).
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The same three authors evaluated and cross-checked the quality of all included articles independently, accord-
ing to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guideline [16]. The 
quality assessment included five domains, namely, sample population, sample size, participation rate, outcome 
assessment, and analytical methods (Table S3 in the Online Supplementary Document). The quality score in 
each domain ranged from zero to two, and the total score represented the overall bias risk.
Statistical analysis
In our data extraction stage, one single article might contribute multiple data points (age- or sex-specific prev-
alence). To best take into account the effect of sample size and fit this hierarchical data structure, we adopted 
a multilevel mixed-effects meta-regression, with sample size as the weights and the combination of study iden-
tification and country identification as the random effect u
i
 [17-19]. To investigate whether the prevalence of 
ET varied across different sample characteristics, we first conducted an age-adjusted meta-regression. The a 
priori selected cluster-level factors included age, sample size, sex (or proportion of female participants), inves-
tigation year, study setting (rural or urban), WHO region, WHO region, study design (one-phase, two-phase 
or three-phase), and participants that were examined (all subjects or the screened positive subjects).
According to the abovementioned models, age, sex and sample size were found to be significantly associated 
with ET. Given that:
prevalence = P = (ET cases) / (number of participants)
Then, the prevalence estimates were first stabilised by the logit transformation,








 + … + u
i
The prevalence of ET was established as a function of age and sex:
logit(p) = α + β
1
 × Age + β
2
 × Female proportion + u
i
Then,
Prevalence = P = e(α + β1 ×  Age + β2 ×  Female proportion + ui) / [1 + e(α + β1 ×  Age + β2 ×  Female proportion + ui)]
Finally, the numbers of people living with ET were generated by multiplying the estimated age- and sex-spe-
cific prevalence rates by the corresponding world populations in 2020, available from the United Nations Pop-
ulation Division (UNPD) [20].
All analyses were performed using R, version 3.3.0 (R Foundation for Statistical Computing, Vienna, Austria). 
The significance level was set as P < 0.05 in two-sided tests for all analyses.
RESULTS
Study selection and characteristics
Figure 1 outlines the selection process for the included ar-
ticles. The initial bibliographic data set searches returned 
771 records, 29 of which were included in our meta-anal-
ysis. These 29 articles, published between 2001 and 2019, 
involved a total of 320668 participants and 2250 cases in 
13 countries (Brazil, China, Denmark, India, Israel, Italy, 
South Korea, Nigeria, Singapore, Spain, Tanzania, Turkey, 
and the United States). Most of the included articles were 
based on two-phase investigations (screening question-
naire followed by neurological evaluation, n = 21, 72.4%), 
conducted the diagnostic evaluation in screen-positive 
subjects (n = 19, 65.6%), and with a quality score of six 
or above (n = 26, 89.7%). The diagnoses in the included 
articles were all made by or under the supervision of neu-
rologists or movement disorder specialists. The detailed 
characteristics and quality appraisal of the identified ar-
ticles are provided in Table S4-S5 in the Online Supple-
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Meta-regression
According to the age-adjusted meta-regression models (Table 1), advancing age was found to be positively as-
sociated with the prevalence of ET, while the prevalence of ET was lower in females than in males (as indicated 
by both the variables “female proportion” and “sex”). In addition, larger investigations tended to yield lower 
prevalence estimates, with sample size being negatively associated with the prevalence of ET in our age-ad-
justed models. However, the prevalence of ET did not significantly differ between rural and urban settings, or 
among different WB and WHO regions. Moreover, no secular trend in the prevalence of ET was revealed, and 
study design (one-, two- and three-phase) and diagnostic strategy (in all subjects or only in screened positive 
subjects) did not seem to have a significant influence on the reported prevalence of ET.
Table 1. Age-adjusted meta-regression models of cluster-level factors related to the prevalence of ET (logit form)
Moderator Number of articles
Number of  
data points β 95% CI P-value
Age 29 160 0.0534 0.0489 to 0.0578 <0.0001
Sample size (per 1000) 29 160 -0.0265 -0.0400 to -0.0129 <0.0001
Investigation year* 29 160 -0.0268 -0.0910 to 0.0374 0.4130
Female proportion 29 160 -0.1538 -0.2609 to -0.0466 0.0049
Sex†
Female 21 64 Reference
Male 21 64 0.1562 0.0490 to 0.2634 0.0043
Setting
Urban 11 64 Reference
Rural 7 31 -1.1013 -2.3803 to 0.1777 0.0915
WB region
HICs 12 64 Reference
LMICs 17 96 0.2293 -1.3289 to 1.7875 0.7730
WHO region
WPR 6 35 Reference
AFR 2 8 -1.1402 -3.9409 to 1.6604 0.4249
AMR 3 14 0.6896 -2.0360 to 3.4151 0.6200
EUR 15 78 0.6125 -1.5419 to 2.7670 0.5774
SEAR 3 25 -0.3832 -3.6722 to 2.9058 0.8194
Study design
One-phase 4 17 Reference
Two-phase 21 128 -0.0401 -1.1733 to 1.0930 0.9447
Three-phase 3 14 -0.4469 -2.2660 to 1.3723 0.6302
Who were examined
All subjects 8 49 Reference
Screened positive subjects 19 101 0.2091 -0.8266 to 1.2448 0.6924
ET – essential tremor, WB – World Bank, HIC – high income country, LMIC – low- and middle-income country, WHO – World Health 
Organization, WPR – Western Pacific Region, AFR – African Region, AMR – Region of the Americas, EUR – European Region, SEAR – 
South-East Asia Region
*Calendar year.
†The effect of sex was estimated based on studies where sex-specific prevalence was available.
Age- and sex-specific prevalence and the number of cases of ET in 2020
Based on 160 data points from the included articles, the relations of age and sex to the prevalence of ET were 
established (Figure 2). Males consistently had higher prevalence rates than females over the whole life span. 
In both sexes, the prevalence of ET gradually but slowly increased with advancing age before middle age, start-
ing from less than 0.05% in young people under 20 years of age (0.04%, 95% CI = 0.01-0.35, in males and 
0.03%, 95% CI = 0.00-0.23, in females). From 60 years of age onwards, this increasing trend started to become 
dramatically pronounced, reaching 3.48% (95% CI = 1.32-8.88) and 2.49% (95% CI = 0.92-6.61) in elderly 
men and women aged 80 years and above respectively. After applying the demographic structure in 2020 (Ta-
ble 2 and Figure 3), the overall prevalence of ET in the general population was 0.32% (95% CI = 0.12-0.91), 
and the prevalence was higher in males (0.36%, 95% CI = 0.14-1.03) than in females (0.28%, 95% CI = 0.11-
0.79). In 2020, the number of people affected by ET was 24.91million (95% CI = 9.51-70.92), among whom 
56% were males.
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Table 2. Estimated age- and sex-specific prevalence and cases of ET in 2020
Age group 
(years)
Prevalence (%, 95% CI) Cases (million, 95% CI)
Male Female Overall Male Female Overall
<20
0.04 0.03 0.04 0.59 0.38 0.97
(0.01-0.35) (0.00-0.23) (0.00-0.29) (0.08-4.68) (0.05-2.90) (0.13-7.58)
20-29
0.10 0.07 0.09 0.64 0.41 1.04
(0.02-0.53) (0.01-0.35) (0.02-0.44) (0.12-3.26) (0.08-2.03) (0.21-5.29)
30-39
0.18 0.13 0.16 1.08 0.71 1.79
(0.05-0.71) (0.03-0.47) (0.04-0.60) (0.28-4.18) (0.19-2.68) (0.47-6.86)
40-49
0.33 0.23 0.28 1.64 1.10 2.73
(0.11-1.00) (0.08-0.66) (0.09-0.83) (0.55-4.89) (0.38-3.20) (0.92-8.08)
50-59
0.59 0.40 0.50 2.46 1.70 4.16
(0.24-1.45) (0.17-0.97) (0.21-1.21) (1.00-6.02) (0.71-4.06) (1.71-10.09)
60-69
1.06 0.73 0.89 3.03 2.22 5.25
(0.48-2.32) (0.33-1.57) (0.40-1.94) (1.37-6.65) (1.02-4.81) (2.39-11.46)
70-79
1.86 1.28 1.54 2.63 2.18 4.81
(0.82-4.13) (0.57-2.85) (0.68-3.43) (1.17-5.86) (0.97-4.86) (2.14-10.72)
≥80
3.48 2.49 2.87 1.94 2.22 4.16
(1.32-8.88) (0.92-6.61) (1.07-7.49) (0.73-4.96) (0.82-5.90) (1.55-10.85)
Overall
0.36 0.28 0.32 14.01 10.90 24.91
(0.14-1.03) (0.11-0.79) (0.12-0.91) (5.31-40.49) (4.20-30.43) (9.51-70.92)
ET – essential tremor, CI – confidence interval
DISCUSSION
This systematic review and meta-analysis of 29 articles published from 2001 to 2019 provided a comprehensive 
and up-to-date assessment of the prevalence of ET worldwide. Based on a substantial number of data points 
from included articles, we revealed that the prevalence of ET increased with advancing age, predominantly in 
elderly aged 60 years and above. Moreover, ET was found to be consistently more common in males than in 
females across the whole life span. In 2020, the global prevalence of ET was 0.32% in the general population, 
ranging from 0.04% in people under 20 years to 2.87% in those aged 80 years and above. The total number 
of people suffering from ET worldwide was 24.91 million in 2020.
The previous systematic review and meta-analysis by ED Louis and colleagues reported a pooled ET preva-
lence of 0.9%, which was much higher than our prevalence estimate of 0.32%. As revealed in our meta-regres-
sion and widely in previous investigations, the prevalence of ET increased exponentially with advancing age 
[3,21,22]. Given that more than half of the included studies in the meta-analysis by ED Louis and colleagues 
Figure 2. Age- and sex-specific prevalence of essential tremor based 
on available data points from the included articles, with 95%  
confidence intervals (CI).
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were conducted in middle-aged (≥40 years) or elderly (≥60 years), it is therefore not surprising to observe a 
relatively higher than expected ET prevalence by their estimation. The great variety of reported ET prevalence 
according to age group leads to the necessity of an age-specific estimation in data synthesis, which led to the 
initiation and then became the most obvious merit of our study. Apart from age, the sex difference in ET prev-
alence is a topic of both clinical and public health interests. Several previous investigations have revealed no 
sex differences in ET prevalence, while some others demonstrated that the prevalence was higher in males 
than in females [3,5]. ET disproportionally affect different regions of the body between sexes, with head and 
voice tremor being more frequent among females and postural hand tremor being more common and more 
severe among males [23]. After controlling the effect of age, a significantly higher prevalence of ET in males 
was revealed in our study, which is consistent with findings in previous primary investigations, especially in 
the paediatric population [3,24]. This phenomenon might be resulted by the impact of sex chromosomes and 
sex hormones [23,25]. Moreover, the possible pathological associations between ET and Parkinson disease 
and the fact that Parkinson disease is more frequent in males might also accumulate more ET cases in males 
than in females [26].
To the best of our knowledge, this study provides the first age- and sex-specific prevalence estimates of ET 
throughout the whole life span, based on up-to-date epidemiological evidence. Benefiting from our compre-
hensive search strategy, we included 29 articles published after 2000. The sufficient data points from the in-
cluded articles guaranteed our availability to construct the age- and sex-specific prevalence estimates of ET, and 
ensured the power of our statistical analyses. Another strength of our study was the representativeness of our 
estimates of the whole population. After controlling for the effect of age, other cluster-level factors, including 
setting (urban vs rural), WB region, WHO regions, study design (one-, two- and three-phase) and even diag-
nostic strategy (in all subjects or only in screened positive subjects) did not seem to influence the prevalence 
of ET significantly, reinforcing the predominant role of age as the greatest driver of ET [21].
Several potential limitations should be considered when interpreting the results of our study. First, the major-
ity of our included articles were based on two- or three-phase investigations and only conducted neurological 
examinations in screen-positive subjects. Although our meta-regression did not indicate study design and di-
agnostic strategy as significant associated factors, we could not fully rule out the heterogeneity introduced by 
variations in studies with different designs. Despite the fact that the diagnoses of ET in the included articles 
were all made by or confirmed by neurologists or movement disorder specialists, an underestimation could 
still be possible given the questionnaire-based screening during the first phase of case ascertainment might 
have omitted a number of positive cases. In line with studies on other neurological disorders, such as Tourette 
syndrome and epilepsy, epidemiological investigations involving larger sample sizes tend to report relatively 
lower prevalence [27,28]. Second, to lower the effect of outliers with small sample sizes, we weighted contrib-
uting data points by sample size. Since larger investigations generally adopted two- or three-phase study de-
signs without a throughout assessment of all participants, overweighting larger studies might bring underesti-
mated prevalence. Third, we only evaluated the effects of a limited number of variables that were commonly 
available in the included articles, many unexamined factors, such as ethnicity, ET subtype, age-of-onset, might 
have contributed to the heterogeneity among included studies. A better understanding of the epidemiological 
distribution of ET across the world should involve more covariates, when relevant evidence becomes available 
in the foreseeable future.
The findings in our study have both clinical and public health implications. The lack of agreed and shared 
tools and definitions in studies on ET has been highlighted, emphasising the need for adopting an interna-
tionally acknowledged diagnostic approach in future epidemiological investigations in ET [4]. Moreover, new 
epidemiological studies should try to address different subtypes of ET, if possible. Considering that older 
adults, and men more than women, are at a substantially higher risk of ET compared to their younger coun-
terparts, more attention to clinical diagnostics and treatment should be given to this population once the 
symptoms of ET appear.
CONCLUSIONS
In conclusion, our study provides a comprehensive estimation of ET prevalence to date, with emphasis on age 
and sex. ET became more common with advancing age, especially in elderly. Males were more likely to have 
ET than females. The adoption of an internationally acknowledged diagnostic strategy is prompted in future 
epidemiological investigations. Given the prominent role of ageing in the development of ET and the global 
ageing context, more people affected by ET are expected in the foreseeable future.
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